Prof Mohammed Mohty speaks to ecancer online at the MyKE20 online meeting about the management of myeloma patients during the COVID-19 pandemic.
He discusses the reasons why COVID is such a threat to patients with haematological malignancies, and how to balance their protection whilst ensuring a high standard of cancer care.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.